RPHM insider filings

Reneo Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-09-26. Screen RPHM transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for RPHM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Reneo Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2024-09-264Leonard Braden Michael — 10% ownerPurchase (P): 29,600 @ $1.41 · Purchase (P): 68,746 @ $1.50EDGAR
2024-09-194Leonard Braden Michael — 10% ownerPurchase (P): 55,300 @ $1.36 · Purchase (P): 806 @ $1.40EDGAR
2024-09-164Leonard Braden Michael — 10% ownerPurchase (P): 36,176 @ $1.40 · Purchase (P): 150,000 @ $1.31 · Purchase (P): 172,747 @ $1.37EDGAR
2024-08-144Leonard Braden Michael — 10% ownerPurchase (P): 171,339 @ $1.39 · Purchase (P): 100,487 @ $1.41EDGAR
2024-05-164Leonard Braden Michael — 10% ownerPurchase (P): 79,281 @ $1.56 · Purchase (P): 335,000 @ $1.54EDGAR
2023-08-294Hall Ashley — Chief Development OfficerOption exercise (M): 15,625 @ $1.80 · Sale (S): 15,625 @ $6.28 · Option exercise (M): 15,625 (derivative) @ $0EDGAR
2023-07-274GREY MICHAEL G — Executive Chairman, DirectorGift (G): 50,000 @ $0EDGAR
2023-06-234Novo Holdings A/S — 10% ownerSale (S): 100,000 @ $7.10EDGAR
2023-06-084Blunt Roshawn A. — DirectorGrant/award (A): 14,815 (derivative) @ $0EDGAR
2023-06-084Muralidhar Bali — DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2023-06-084O'Donnell Niall — DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2023-06-084Seltzer Stacey Denenberg — DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2023-06-084Dube Eric M — DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2023-06-084Hoelscher Paul W. — DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2023-06-084Mathers Edward T — DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2023-06-084GREY MICHAEL G — Executive Chairman, DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2023-05-104O'Donnell Niall — DirectorPurchase (P): 125,000 @ $8EDGAR
2022-12-134Lam Jennifer — VP of Finance & AdministrationGrant/award (A): 90,000 (derivative) @ $0EDGAR
2022-12-134Hall Ashley — Chief Development OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2022-12-134FLESHER GREGORY J. — President and CEO, DirectorGrant/award (A): 300,000 (derivative) @ $0EDGAR
2022-12-134Cruse Michael — Chief Operating OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2022-12-134Dorenbaum Alejandro — Chief Medical OfficerGift (G): 22,348 @ $0 · Grant/award (A): 125,000 (derivative) @ $0EDGAR
2022-09-024Cruse Michael — Chief Operating OfficerPurchase (P): 7,500 @ $3.39EDGAR
2022-09-024GREY MICHAEL G — Executive Chairman, DirectorOption exercise (M): 50,000 @ $1.97 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2022-08-314Cruse Michael — Chief Operating OfficerPurchase (P): 83 @ $3.24 · Purchase (P): 1,140 @ $3.24 · Purchase (P): 975 @ $3.16 · Purchase (P): 1,845 @ $3.19 · Purchase (P): 3,212 @ $3.21EDGAR
2022-08-024Blunt Roshawn A. — DirectorGrant/award (A): 35,000 (derivative) @ $0EDGAR
2022-06-034Dube Eric M — DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2022-06-034Muralidhar Bali — DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2022-06-034O'Donnell Niall — DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2022-06-034Seltzer Stacey Denenberg — DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2022-06-034Hoelscher Paul W. — DirectorGrant/award (A): 6,376 (derivative) @ $0EDGAR
2022-06-034Mathers Edward T — DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2022-06-034GREY MICHAEL G — Executive Chairman, DirectorGrant/award (A): 17,500 (derivative) @ $0EDGAR
2022-03-044Cruse Michael — Chief Operating OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-244Hoelscher Paul W. — DirectorGrant/award (A): 35,000 (derivative) @ $0EDGAR
2021-12-144Jindal Vineet R. — Chief Financial OfficerGrant/award (A): 30,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-12-144FLESHER GREGORY J. — President and CEO, DirectorGrant/award (A): 100,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2021-12-144Cruse Michael — Senior VP-Corporate OperationsGrant/award (A): 25,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2021-12-144Dorenbaum Alejandro — Chief Medical OfficerGrant/award (A): 30,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-11-154Hall Ashley — Chief Development OfficerGrant/award (A): 30,000 @ $0 · Grant/award (A): 180,000 (derivative) @ $0EDGAR
2021-08-264Jindal Vineet R. — Chief Financial OfficerPurchase (P): 5,000 @ $7.44EDGAR
2021-08-264FLESHER GREGORY J. — President and CEO, DirectorPurchase (P): 8,000 @ $8EDGAR
2021-08-264Cruse Michael — Senior VP-Corporate OperationsPurchase (P): 2,500 @ $7.45EDGAR
2021-07-154Muralidhar Bali — DirectorPurchase (P): 111,736 @ $8.50EDGAR
2021-07-154Johnson Wendy S. — Chief Development OfficerSale (S): 111,736 @ $8.50EDGAR
2021-07-094Johnson Wendy S. — Chief Development OfficerOption exercise (M): 111,736 @ $1.97 · Option exercise (M): 111,736 (derivative) @ $0EDGAR
2021-06-254Muralidhar Bali — DirectorPurchase (P): 20,710 @ $9.28EDGAR
2021-06-234Muralidhar Bali — DirectorPurchase (P): 32,659 @ $9.03 · Purchase (P): 14,615 @ $8.72EDGAR
2021-06-104Muralidhar Bali — DirectorPurchase (P): 16,605 @ $9.50EDGAR
2021-06-074Muralidhar Bali — DirectorPurchase (P): 12,100 @ $9.25 · Purchase (P): 257 @ $9.42EDGAR

Recent 8-K events — Reneo Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-138-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-048-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-308-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-068-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RPHM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs